Atlas Trials

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment

Clinical trial NCT05813418 · RECRUITING

Trial details

NCT number
NCT05813418
Sponsor
Centre Hospitalier Universitaire, Amiens
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
ImmunotherapyImmune Checkpoint InhibitorsImmune-related Adverse EventPredictive Biomarkers
Start date
2021-07-02
Primary completion
2025-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.